https://www.socialpharmaceuticalinnovation.org/pt/post/o-protocolo-holandês-de-acesso-a-medicamentos-órfãos 2022-11-03 https://static.wixstatic.com/media/25896a_98575e4d9c2d4091aa1768697a43bab1~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/coordenador-do-projeto-spin-participa-de-consulta-pública-sobre-medicamentos-de-alto-custo 2021-04-08 https://static.wixstatic.com/media/476a99_69280f1cbf344ff1ad9d598187e96b95~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/ats-da-tecnocracia-global-a-democracia-sustentável 2022-12-14 https://static.wixstatic.com/media/25896a_955d929bbd7f4ef18d2c7dc68bffc66e~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/ensaios-clínicos-descentralizados-como-o-lugar-afeta-os-dados 2023-02-22 https://static.wixstatic.com/media/25896a_d48970d4e29c4d2dbed436a9d7c07c22~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/pesquisa-de-doenças-raras-na-europa-a-academia-responderá-ao-desafio-1 2020-12-12 https://static.wixstatic.com/media/476a99_281d1fe28d6f424b91c43696772ee8af~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/pharmacare-do-canadá-promessas-grandiloquentes-e-entregas-tímidas 2021-05-15 https://static.wixstatic.com/media/476a99_5ab0c47e5e8946839fc91817af4cf1d8~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/o-papel-dos-registros-de-pacientes-em-doenças-raras 2023-01-26 https://static.wixstatic.com/media/476a99_55f7d399909f4d80ad174b16846f2989~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/monitoramento-de-horizonte-olhando-para-frente-mas-que-tal-olhar-para-trás-1 2021-01-14 https://static.wixstatic.com/media/476a99_568b1f45104346b5a810d7bde62fc4d9~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/o-que-conta-na-precificação-de-medicamentos 2022-07-24 https://static.wixstatic.com/media/25896a_13f72fd3af8843c6ba83490326335160~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/cópia-de-o-impacto-da-covid-19-sobre-canadenses-com-doenças-raras 2020-10-10 https://static.wixstatic.com/media/a27d24_73e5dd129ecc460eb8bd5e7e5d4788aa~mv2.png https://www.socialpharmaceuticalinnovation.org/pt/post/cópia-de-consentimento-coletivo-para-pagar-o-que-é-levado-em-conta-e-o-que-deveria-ser 2021-11-11 https://static.wixstatic.com/media/e12d4f_7dc0bd0a08b24243ac8a7168886cef60~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/vigilância-genômica-a-chave-para-a-saúde-pública-canadense 2023-01-05 https://static.wixstatic.com/media/25896a_9feb6eac53b4482390119290a4ea602b~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/projeto-farmacêutico-da-academia-recebe-designação-de-medicamento-órfão 2022-07-04 https://static.wixstatic.com/media/476a99_31d90c10c54740c29adefd76297eeb6d~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/nexviayme-aprovado-par-doenças-de-pompe-pela-health-canada 2022-01-31 https://static.wixstatic.com/media/9d2844_46b3b23892c04a43b486a899804163aa~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/doença-rara-na-mídia-documentário-bend-or-break-destaca-necessidades-médicas-não-atendidas 2021-12-23 https://static.wixstatic.com/media/25896a_5bca99b565b84774a32ad639e39d7f4b~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/medicamentos-órfãos-no-contexto-holandês-uma-questão-de-necessidade-1 2020-11-13 https://static.wixstatic.com/media/9d2844_5089f61ba30741bf9ee3a9c0d5dcb597~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/primeira-terapia-gênica-é-aprovada-no-canadá-1 2021-01-12 https://static.wixstatic.com/media/476a99_7b10bb1970c94771a71554861131b1b9~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/definindo-valores-para-o-desenvolvimento-de-registro-de-pacientes 2022-07-18 https://static.wixstatic.com/media/25896a_41de9ca498d3429aa66246aa1c2cd4c3~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/enquadrando-o-problema-perverso-das-doenças-raras 2022-12-13 https://static.wixstatic.com/media/25896a_1f07016d80664b299ddaf5eb1b3667d3~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/terapia-gênica-para-doença-de-fabry-um-sonho-abandonado 2022-02-21 https://static.wixstatic.com/media/25896a_6671ab66f2b743e885ae2253f76f9213~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/cópia-de-o-remédio-mais-caro-do-mundo-e-os-falsos-dilemas 2021-11-11 https://static.wixstatic.com/media/9d2844_7c2b4aba4a9749af801a63d919821c92~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/doenças-ultra-raras-e-a-necessidade-de-inventar-um-novo-modelo-de-negócios 2023-01-25 https://static.wixstatic.com/media/25896a_3431ce9bb9314cd392fe11e17dcebd18~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/preparando-o-futuro-da-inovação-terapêutica-e-social-a-iniciativa-das-organizações-de-pacientes 2022-10-06 https://static.wixstatic.com/media/25896a_9d4a854815a84729949b641cbc5b0bbe~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/direito-à-saúde-e-doenças-raras-no-brasil-1 2021-03-22 https://static.wixstatic.com/media/9d2844_1514e03de372452f8338820668662611~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/vale-a-pena-acompanhar-reformas-de-políticas-européias-farmacêuticas-no-futuro-próximo 2022-04-08 https://static.wixstatic.com/media/25896a_016e53874468484898605ad8467e3280~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/solidariedade-no-crowdfunding-para-tratamento-de-doenças-raras 2023-01-23 https://static.wixstatic.com/media/25896a_de1e3122165c4ffabf945d11303bd8a2~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/health-canadá-lança-consulta-pública-para-sua-política-em-doenças-raras-1 2021-02-12 https://static.wixstatic.com/media/476a99_14cd9ac619ca47f7901a1c154abf2bed~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/do-estudo-à-intervenção-avançando-na-inovação-social-farmacêutica 2023-01-30 https://static.wixstatic.com/media/25896a_b99098b3c5704df5b17294fa26ae0d84~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/colonialismo-científico-em-doenças-raras-novas-diretrizes-éticas 2022-10-14 https://static.wixstatic.com/media/9d2844_010820c6f94a4a9c9e7bc281345fa90e~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/judicialização-de-baixo-para-cima-a-revolução-possível-1 2020-12-18 https://static.wixstatic.com/media/9d2844_3c08b0775a5241979fd24f4bddb28d53~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/comuns-uma-proposta-para-redesenhar-a-governança-do-conhecimento-e-da-tecnologia 2022-03-09 https://static.wixstatic.com/media/25896a_9fd9aafd793d4204a30931f96bdc7347~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/o-limitador-de-preços-é-a-solução-para-medicamentos-para-doenças-raras-no-canadá 2020-11-05 https://static.wixstatic.com/media/a27d24_9337f27251b74d9095d7991f67d84d43~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/combinando-dinheiro-e-saúde-na-política-holandesa-de-terapias-acessíveis-e-sustentáveis 2021-11-23 https://static.wixstatic.com/media/476a99_1c59a97a29e1417aa99b998a990ab9ad~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/spin-na-prática-em-conferências-científicas-de-pacientes-e-políticas-no-canadá 2023-01-30 https://static.wixstatic.com/media/476a99_cf364bee13224b6787c390b8ccc0c9f2~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/encurralado-entre-uma-doença-rara-e-a-covid-19-1 2021-02-19 https://static.wixstatic.com/media/9d2844_0b6e3e085a11437cb0d1eac0da4d1a61~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/parcerias-público-privadas-e-inovação-social-farmacêutica-no-brasil 2022-08-09 https://static.wixstatic.com/media/9d2844_18e34c2bfa7846cbab9505317335bf37~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/sistemas-federados-e-o-gap-de-dados-de-saúde-no-canadá-tornando-se-grande-com-big-data 2022-02-07 https://static.wixstatic.com/media/25896a_74617230391f4fc483cf9d2379797cb7~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/a-dependência-científica-e-política-da-agência-nacional-de-ats-no-brasil 2022-02-26 https://static.wixstatic.com/media/9d2844_3c08b0775a5241979fd24f4bddb28d53~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/livro-da-big-pharma-aos-comuns-commons 2023-01-24 https://static.wixstatic.com/media/25896a_0311f52061644edea1b87317c1acf58e~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/spinraza-tem-reembolso-negado-para-canadenses-com-atrofia-muscular-espinhal-tipos-ii-e-iii 2022-09-09 https://static.wixstatic.com/media/25896a_13dc9a95fb3d4cd1ac9db14a1f0bb7fa~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/kalydeco-aprovado-para-crianças-com-fc-no-canadá-a-importância-de-registros-de-pacientes-e-advocacy 2022-04-13 https://static.wixstatic.com/media/25896a_80cc609417b946989f04cb4d4fe51c9e~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/foco-nas-histórias-de-pacientes 2022-08-04 https://static.wixstatic.com/media/25896a_2cd7e195e2c7454ea6f3bc7205045cde~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/alternativas-existem-do-diagnóstico-ao-tratamento-com-terapia-gênica-em-três-anos 2022-11-10 https://static.wixstatic.com/media/25896a_15b5180b32154ac58e6df341bcec1091~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/desafios-enfrentados-pelos-sistemas-públicos-de-saúde-demandam-pactos-de-inovação-farmacêutica 2022-03-25 https://static.wixstatic.com/media/9d2844_6442b8f816534c65ba64080031a111a0~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/redes-de-pesquisa-em-ciências-sociais-e-doenças-raras-começam-a-despontar 2022-03-17 https://static.wixstatic.com/media/476a99_bcdf42f49b47488ea105344e4b26afd3~mv2.gif https://www.socialpharmaceuticalinnovation.org/pt/post/técnica-aumenta-eficácia-do-tratamento-car-t-em-tumores-sólidos 2022-07-14 https://static.wixstatic.com/media/476a99_da6590a6081c4810a3b45175680e34ef~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/indústria-farmacêutica-oferece-1-bilhão-de-dólares-ao-canadá-para-evitar-redução-de-preços-1 2020-12-07 https://static.wixstatic.com/media/476a99_0042daffcc584c33804ea65983c19c43~mv2.jpg https://www.socialpharmaceuticalinnovation.org/pt/post/prospectiva-em-doenças-raras-como-devem-ser-as-futuras-políticas-neste-campo-1 2021-03-12 https://static.wixstatic.com/media/476a99_47ba620de0854dd0bb4c8b7cd0c47ab2~mv2.jpg